Insulin Icodec Study for Type 1 Diabetes Begins Enrollment
The clinical trial for insulin icodec, designated NCT07160816, has commenced enrollment, focusing on its efficacy in controlling blood sugar levels in individuals with type 1 diabetes over a treatment duration of 22 to 30 weeks.